⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STTK News
Shattuck Labs, Inc. Common Stock
Form 8-K
sec.gov
STTK
Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
STTK
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
globenewswire.com
STTK
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
globenewswire.com
STTK
Sins of a Solar Empire II: Harbinger Arrives with the Deadly Eidolon Faction
prnewswire.com
STTK
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
globenewswire.com
STTK
Form 8-K
sec.gov
STTK
Shattuck Labs Reports Second Quarter 2026 Financial Results and Recent Business Highlights
globenewswire.com
STTK
Form 8-K
sec.gov
STTK
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
globenewswire.com
STTK